ReviewExperientia supplementum (2012)
Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.
Mina M Benjamin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
75 papers cite itlatest 60 shown
trialcites it